DE3585618D1 - Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns. - Google Patents

Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns.

Info

Publication number
DE3585618D1
DE3585618D1 DE8585905362T DE3585618T DE3585618D1 DE 3585618 D1 DE3585618 D1 DE 3585618D1 DE 8585905362 T DE8585905362 T DE 8585905362T DE 3585618 T DE3585618 T DE 3585618T DE 3585618 D1 DE3585618 D1 DE 3585618D1
Authority
DE
Germany
Prior art keywords
growth factor
stimulation
cure
wound
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585905362T
Other languages
English (en)
Inventor
L Brown
Richard Eiferman
L Schultz
D Valenzuela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
University of Louisville Research Foundation ULRF
Original Assignee
University of Louisville Research Foundation ULRF
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Louisville Research Foundation ULRF, Chiron Corp filed Critical University of Louisville Research Foundation ULRF
Application granted granted Critical
Publication of DE3585618D1 publication Critical patent/DE3585618D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF] (urogastrone)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE8585905362T 1984-10-19 1985-10-16 Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns. Expired - Lifetime DE3585618D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66309284A 1984-10-19 1984-10-19
PCT/US1985/002024 WO1986002271A1 (en) 1984-10-19 1985-10-16 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna

Publications (1)

Publication Number Publication Date
DE3585618D1 true DE3585618D1 (de) 1992-04-16

Family

ID=24660436

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585905362T Expired - Lifetime DE3585618D1 (de) 1984-10-19 1985-10-16 Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns.

Country Status (6)

Country Link
US (1) US4959353A (de)
EP (1) EP0200757B1 (de)
JP (1) JPH0611709B2 (de)
AT (1) ATE73345T1 (de)
DE (1) DE3585618D1 (de)
WO (1) WO1986002271A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
US5366081A (en) * 1987-08-26 1994-11-22 United States Surgical Corporation Packaged synthetic absorbable surgical elements
EP0339905A3 (de) * 1988-04-25 1991-05-08 Ethicon, Inc. Wachstumfaktoren und Retinoiden enthaltende Wundheilungzusammensetzungen
US5102789A (en) * 1989-03-15 1992-04-07 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of epideramal growth factor in pichia pastoris yeast cells
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5271939A (en) * 1988-10-03 1993-12-21 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5124392A (en) * 1988-10-03 1992-06-23 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
WO1991005863A1 (en) * 1989-10-11 1991-05-02 Pitman-Moore Australia Limited Recombinant growth factors
US5252342A (en) * 1990-03-05 1993-10-12 The Regents Of The University Of California Enhancement of anti-neoplastic drug efficacy using EGF
US5597798A (en) * 1990-03-05 1997-01-28 The Regents Of The University Of California Taxol and epidermal growth factor used to enhance treatment of ovarian cancer
US20030186913A1 (en) * 1990-03-21 2003-10-02 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
IT1240683B (it) * 1990-04-26 1993-12-17 Zambon Spa Composizione farmaceutica contenente egf
US5219998A (en) * 1990-06-04 1993-06-15 Levin Robert H Yeast-derived epidermal growth factor
US5434135A (en) * 1990-08-02 1995-07-18 Indu Parikh Growth factor compositions, preparation and use
US5360790A (en) * 1990-12-11 1994-11-01 The Regents Of The University Of Michigan Method and formulations for the therapy of acute renal failure
CA2059245C (en) * 1991-02-08 2004-07-06 Michael P. Chesterfield Method and apparatus for calendering and coating/filling sutures
WO1993007891A1 (en) * 1991-10-15 1993-04-29 Gastrone, Inc. Epidermal growth factor therapy for non-gastroduodenal lesions
FR2684301B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
EP0648264A4 (de) * 1992-06-03 1997-10-01 Univ Case Western Reserve Permanenter verband zur verabreichung von biologischen produkten.
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5955430A (en) * 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US6048545A (en) * 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
US5904716A (en) * 1995-04-26 1999-05-18 Gendler; El Method for reconstituting cartilage tissue using demineralized bone and product thereof
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
US6525018B1 (en) 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6949528B1 (en) * 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
AU2173400A (en) * 1998-12-09 2000-06-26 Chiron Corporation Method for administering agents to the central nervous system
US7273618B2 (en) 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
WO2003015747A1 (en) 2001-08-13 2003-02-27 Genomed, Llc Method to treat pulmonary hypoplasia in the newborn
TWI348912B (en) 2002-03-12 2011-09-21 Method and composition for treating skin wounds with epidermal growth factor
CA2498717A1 (en) * 2002-09-13 2004-03-25 Ocular Sciences, Inc. Devices and methods for improving vision
US20050275799A1 (en) * 2004-03-10 2005-12-15 Marmo J C Contact lenses, package systems, and method for promoting a healthy epithelium of an eye
CN1972643A (zh) 2004-05-20 2007-05-30 库柏维景公司 用于提高视力的角膜覆盖物和波前像差矫正
US7883520B2 (en) 2006-04-10 2011-02-08 Forsight Labs, Llc Corneal epithelial pocket formation systems, components and methods
US20090192554A1 (en) 2008-01-29 2009-07-30 Confluent Surgical, Inc. Bioabsorbable block copolymer
US9283172B2 (en) 2013-12-13 2016-03-15 Growgene Biotech Inc. Use of stem cell conditioned medium to induce ZO-1 proteins expression for skin regeneration, repair and firming
CN114470312B (zh) * 2022-01-28 2022-12-13 福州大学 一种无泄漏封包酵母水凝胶及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK339781A (da) * 1980-08-05 1982-02-06 Searle & Co Syntetisk gen
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
JPS5965020A (ja) * 1982-10-04 1984-04-13 J- C R Kk 点眼剤
EP0116201B1 (de) * 1983-01-12 1992-04-22 Chiron Corporation Sekretorische Expression in Eukaryoten
JPS59196820A (ja) * 1983-04-20 1984-11-08 Nippon Chem Res Kk ヒト上皮細胞増殖因子の熱処理方法
US4588684A (en) * 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions

Also Published As

Publication number Publication date
US4959353A (en) 1990-09-25
EP0200757B1 (de) 1992-03-11
JPS63502985A (ja) 1988-11-02
EP0200757A4 (de) 1987-04-10
EP0200757A1 (de) 1986-11-12
JPH0611709B2 (ja) 1994-02-16
WO1986002271A1 (en) 1986-04-24
ATE73345T1 (de) 1992-03-15

Similar Documents

Publication Publication Date Title
DE3585618D1 (de) Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns.
SE8404243L (sv) Forfarande och anordning for elektro-terapeutisk behandling
YU55389A (en) Process for obtaining mixture for stimulating binding of mineralised tissue
ATE40525T1 (de) Vorrichtung zur physiologischen frequenzsteuerung eines mit einer reizelektrode versehenen herzschrittmachers.
IT1142950B (it) Procedimento per la produzione di urogastrone fattore di crescita epidermica umana
ES540447A0 (es) Un metodo de preparar un vendaje
DE69221369T2 (de) Verfahren zur Herstellung eines Konzentrates von Blutgerinnungsfaktor XI mit hoher spezifischer Aktivität zur therapeutischen Verwendung
ATE95694T1 (de) Verwendung von bezafibrat zur behandlung von diabetes.
DE69115687D1 (de) Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese
ES2025562T3 (es) Vendajes laminados.
ATE245409T1 (de) Verwendung von carbonsäuren mit einer schwefelhaltigen funktionellen gruppe zur förderung der hautabschälung bzw. stimulierung der epidermisregeneration
DE3873188D1 (de) Verwendung von nigerizin zur herstellung eines mittels zur behandlung von virus-erkrankungen.
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
ES2005926A6 (es) Aparato de estimulacion de la piel mediante una senal electromagnetica.
AR231913A1 (es) Instrumento electromedico para tratar tejido vivo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition